New York Life Investment Management’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-5,195
| Closed | -$380K | – | 1123 |
|
|
2024
Q1 | $380K | Buy |
5,195
+464
| +10% | +$33.9K | ﹤0.01% | 849 |
|
|
2023
Q4 | $338K | Sell |
4,731
-110
| -2% | -$7.86K | ﹤0.01% | 1142 |
|
|
2023
Q3 | $290K | Sell |
4,841
-761
| -14% | -$45.6K | ﹤0.01% | 1176 |
|
|
2023
Q2 | $404K | Sell |
5,602
-949
| -14% | -$68.4K | ﹤0.01% | 988 |
|
|
2023
Q1 | $482K | Buy |
+6,551
| New | +$482K | 0.01% | 864 |
|